Tenet Healthcare (THC)
(Real Time Quote from BATS)
$124.00 USD
+1.64 (1.34%)
Updated May 7, 2024 03:49 PM ET
After-Market: $124.11 +0.11 (0.09%) 4:06 PM ET
1-Strong Buy of 5 1
A Value C Growth A Momentum A VGM
Price, Consensus and EPS Surprise
THC 124.00 +1.64(1.34%)
Will THC be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for THC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for THC
Zacks.com featured highlights include SkyWest, Powell Industries, Minerals Technologies, The Vita Coco and Tenet Healthcare
4 Sector ETFs & Stocks Likely to Benefit Despite Soft Jobs Data
THC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?
Other News for THC
Cannabis In Sports Medicine: Here's What Doctors Really Think
Insider Sale: EVP Thomas Arnst Sells 8,148 Shares of Tenet Healthcare Corp (THC)
Tenet Healthcare price target raised by $34 at Barclays, here's why
Barclays Reaffirms Their Buy Rating on Tenet Healthcare (THC)
Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), GE Healthcare Technologies Inc (GEHC) and Tenet Healthcare (THC)